Myung-Ho Bae Selected Research

(3- (4- (2(4- (4chloro- phenyl)- 3,6- dihydro- 2H- pyridin- 1- yl)- ethoxy)- phenyl)- (2S)- ethoxy- propionic acid)

10/2008

PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myung-Ho Bae Research Topics

Disease

2	Neoplasms (Cancer) 01/2018 - 10/2004
2	Insulin Resistance 01/2011 - 10/2008
2	Hypoxia (Hypoxemia) 10/2004 - 01/2002
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Hyperglycemia 01/2011
1	Hepatocellular Carcinoma (Hepatoma) 10/2008

Drug/Important Bio-Agent (IBA)

2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2011 - 10/2008
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	2- ethoxy- 3- (4- (3- methyl- 5- (4- (3- methylisoxazol- 5- yl)phenyl)thiophen- 2- ylmethoxy)phenyl)propionic acidIBA 01/2011
1	(3- (4- (2(4- (4chloro- phenyl)- 3,6- dihydro- 2H- pyridin- 1- yl)- ethoxy)- phenyl)- (2S)- ethoxy- propionic acid)IBA 10/2008
1	Glucose (Dextrose)FDA LinkGeneric 10/2008
1	Insulin (Novolin)FDA Link 10/2008
1	LipidsIBA 10/2008
1	PPAR alphaIBA 10/2008
1	CytokinesIBA 10/2004
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2004
1	Epidermal Growth Factor (EGF)IBA 10/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2004
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 10/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2002
1	Oxygen (Dioxygen)IBA 01/2002
1	Transcription Factors (Transcription Factor)IBA 01/2002
1	Erythropoietin FDA Link 01/2002
1	EnzymesIBA 01/2002

Therapy/Procedure

1	Precision Medicine 01/2018